...
首页> 外文期刊>The Indian journal of tuberculosis >MDR-TB - INTERVENTIONAL STRATEGY
【24h】

MDR-TB - INTERVENTIONAL STRATEGY

机译:耐多药结核病-干预策略

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

At the outset I would like to thank TB Association of India and its key functionaries namely, the Chairman Dr. R.K. Srivastava, Vice Chairmen, Dr. V.K. Arora and Dr. M.M. Singh and all others who have selected me for this prestigious Oration. I would also like to thank Dr. O.A. Sarma for instituting such an award which motivates the TB workers in the country. Lastly I would like to thank my teachers, the LRS Institute of TB & RD and all my patients who have been my guiding spirit in the battle against TB. On deciding for the topic of this lecture, I have selected one of the major emerging threats to TB Control i.e. Multi Drug Resistant TB (MDR) and would accordingly deliberate on "MDR-TB Interventional Strategy".
机译:首先,我要感谢印度结核病协会及其主要职能部门的主席R.K. Dr. Srivastava副主席V.K.博士Arora和M.M.博士辛格(Singh)和所有其他选择我参加此著名演说的人。我还要感谢O.A.博士萨马(Sarma)设立了这样的奖项,以激励该国的结核病工作者。最后,我要感谢我的老师,LRS TB和RD研究所以及所有我的患者,他们一直是我抗击结核病的指导精神。在确定本讲座的主题时,我选择了结核病控制的主要新兴威胁之一,即耐多药结核病(MDR),因此将考虑“ MDR-TB干预策略”。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号